
Sign up to save your podcasts
Or


It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.
By Mark Ebell4.7
9292 ratings
It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.

134 Listeners

701 Listeners

504 Listeners

298 Listeners

305 Listeners

264 Listeners

3,374 Listeners

1,150 Listeners

194 Listeners

94 Listeners

518 Listeners

367 Listeners

251 Listeners

375 Listeners

320 Listeners